Hussman Strategic Advisors Inc. bought a new position in Genpact Limited (NYSE:G - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 84,000 shares of the business services provider's stock, valued at approximately $3,697,000. Genpact makes up approximately 0.8% of Hussman Strategic Advisors Inc.'s investment portfolio, making the stock its 27th biggest holding.
Several other large investors have also recently bought and sold shares of G. Cornerstone Planning Group LLC bought a new position in shares of Genpact in the first quarter worth $27,000. Richardson Financial Services Inc. bought a new position in Genpact in the 1st quarter worth about $35,000. Steph & Co. purchased a new stake in shares of Genpact in the 2nd quarter valued at about $37,000. SVB Wealth LLC purchased a new stake in shares of Genpact in the 1st quarter valued at about $41,000. Finally, Kestra Investment Management LLC bought a new stake in shares of Genpact during the 1st quarter valued at about $56,000. 96.03% of the stock is owned by institutional investors.
Genpact Stock Performance
Genpact stock opened at $38.08 on Tuesday. The firm has a fifty day simple moving average of $41.54 and a two-hundred day simple moving average of $43.50. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.32. Genpact Limited has a twelve month low of $37.49 and a twelve month high of $56.76. The company has a market capitalization of $6.64 billion, a PE ratio of 12.65, a P/E/G ratio of 1.31 and a beta of 0.85.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The business services provider reported $0.88 EPS for the quarter, topping the consensus estimate of $0.85 by $0.03. The firm had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.23 billion. Genpact had a return on equity of 22.15% and a net margin of 10.92%.The company's quarterly revenue was up 6.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.79 earnings per share. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. Research analysts expect that Genpact Limited will post 3.21 EPS for the current year.
Genpact Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 23rd. Stockholders of record on Tuesday, December 9th will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Tuesday, December 9th. Genpact's dividend payout ratio is 22.59%.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on G shares. Weiss Ratings restated a "hold (c)" rating on shares of Genpact in a research report on Wednesday, October 8th. Wall Street Zen lowered shares of Genpact from a "buy" rating to a "hold" rating in a report on Friday, September 5th. JPMorgan Chase & Co. lowered their price objective on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 20th. Needham & Company LLC upped their target price on shares of Genpact from $50.00 to $53.00 and gave the stock a "buy" rating in a research report on Friday, August 8th. Finally, Citigroup upgraded Genpact to a "hold" rating in a research report on Thursday, October 23rd. Three research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $51.13.
Read Our Latest Stock Analysis on Genpact
Insider Activity at Genpact
In related news, CEO Balkrishan Kalra sold 55,000 shares of Genpact stock in a transaction on Thursday, September 11th. The shares were sold at an average price of $43.36, for a total value of $2,384,800.00. Following the transaction, the chief executive officer directly owned 295,246 shares of the company's stock, valued at $12,801,866.56. The trade was a 15.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Piyush Mehta sold 76,902 shares of the company's stock in a transaction on Friday, September 12th. The shares were sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the sale, the senior vice president owned 134,880 shares of the company's stock, valued at $5,743,190.40. This represents a 36.31% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 2.80% of the stock is currently owned by company insiders.
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.